SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-12-171702
Filing Date
2012-04-20
Accepted
2012-04-20 06:12:31
Documents
5

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 d314654dposam.htm POS AM 313037
2 OPINION OF DLA PIPER LLP (US) d314654dex51.htm EX-5.1 31058
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM d314654dex231.htm EX-23.1 1802
4 GRAPHIC g314654cov_1pg001.jpg GRAPHIC 12026
5 GRAPHIC g314654ex5_1pg001.jpg GRAPHIC 7706
  Complete submission text file 0001193125-12-171702.txt   374396
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-180131 | Film No.: 12769508
SIC: 2834 Pharmaceutical Preparations